Literature DB >> 22072062

ER stress sensitizes cells to TRAIL through down-regulation of FLIP and Mcl-1 and PERK-dependent up-regulation of TRAIL-R2.

Rosa Martín-Pérez1, Maho Niwa, Abelardo López-Rivas.   

Abstract

Despite recent evidences suggesting that agents inducing endoplasmic reticulum (ER) stress could be exploited as potential antitumor drugs in combination with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), the mechanisms of this anticancer action are not fully understood. Moreover, the effects of ER stress and TRAIL in nontransformed cells remain to be investigated. In this study we report that ER stress-inducing agents sensitizes both transformed and nontransformed cells to TRAIL-induced apoptosis. In addition, glucose-regulated protein of 78 kDa (GRP78) knockdown by RNA interference induces ER stress and facilitates apoptosis by TRAIL. We demonstrate that TRAIL death-inducing signaling complex (DISC) formation and early signaling are enhanced in ER stressed cells. ER stress alters the cellular levels of different apoptosis-related proteins including a decline in the levels of FLIP and Mcl-1 and the up-regulation of TRAIL-R2. Up-regulation of TRAIL-R2 following ER stress is dependent on the expression of PKR-like ER kinase (PERK) and independent of CAAT/enhancer binding protein homologous protein (CHOP) and Ire1α. Silencing of TRAIL-R2 expression by siRNA blocks the ER stress-mediated sensitization to TRAIL-induced apoptosis. Furthermore, simultaneous silencing of cFLIP and Mcl-1 expression by RNA interference results in a marked sensitization to TRAIL-induced apoptosis. Finally, in FLIP-overexpressing cells ER stress-induced sensitization to TRAIL-activated apoptosis is markedly reduced. In summary, our data reveal a pleiotropic mechanism involving both apoptotic and anti-apoptotic proteins for the sensitizing effect of ER stress on the regulation of TRAIL receptor-mediated apoptosis in both transformed and nontransformed cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22072062      PMCID: PMC4096301          DOI: 10.1007/s10495-011-0673-2

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  55 in total

Review 1.  Integrated endoplasmic reticulum stress responses in cancer.

Authors:  Michel Moenner; Olivier Pluquet; Marion Bouchecareilh; Eric Chevet
Journal:  Cancer Res       Date:  2007-11-15       Impact factor: 12.701

2.  Coupling of endoplasmic reticulum stress to CDDO-Me-induced up-regulation of death receptor 5 via a CHOP-dependent mechanism involving JNK activation.

Authors:  Wei Zou; Ping Yue; Fadlo R Khuri; Shi-Yong Sun
Journal:  Cancer Res       Date:  2008-09-15       Impact factor: 12.701

Review 3.  Signal integration in the endoplasmic reticulum unfolded protein response.

Authors:  David Ron; Peter Walter
Journal:  Nat Rev Mol Cell Biol       Date:  2007-07       Impact factor: 94.444

4.  Endoplasmic reticulum stress-induced death of mouse embryonic fibroblasts requires the intrinsic pathway of apoptosis.

Authors:  Ali Masud; Alexander Mohapatra; Saquib A Lakhani; Anthony Ferrandino; Razqallah Hakem; Richard A Flavell
Journal:  J Biol Chem       Date:  2007-03-19       Impact factor: 5.157

5.  Flavopiridol induces cellular FLICE-inhibitory protein degradation by the proteasome and promotes TRAIL-induced early signaling and apoptosis in breast tumor cells.

Authors:  Carmen Palacios; Rosario Yerbes; Abelardo López-Rivas
Journal:  Cancer Res       Date:  2006-09-01       Impact factor: 12.701

6.  Tunicamycin sensitizes human melanoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by up-regulation of TRAIL-R2 via the unfolded protein response.

Authors:  Chen Chen Jiang; Li Hua Chen; Susan Gillespie; Kelly A Kiejda; Nizar Mhaidat; Yu Fang Wang; Rick Thorne; Xu Dong Zhang; Peter Hersey
Journal:  Cancer Res       Date:  2007-06-15       Impact factor: 12.701

Review 7.  Directing cancer cells to self-destruct with pro-apoptotic receptor agonists.

Authors:  Avi Ashkenazi
Journal:  Nat Rev Drug Discov       Date:  2008-11-07       Impact factor: 84.694

8.  Combination therapy of established cancer using a histone deacetylase inhibitor and a TRAIL receptor agonist.

Authors:  Ailsa J Frew; Ralph K Lindemann; Ben P Martin; Christopher J P Clarke; Janelle Sharkey; Desiree A Anthony; Kellie-Marie Banks; Nicole M Haynes; Pradnya Gangatirkar; Kym Stanley; Jessica E Bolden; Kazuyoshi Takeda; Hideo Yagita; J Paul Secrist; Mark J Smyth; Ricky W Johnstone
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-06       Impact factor: 11.205

9.  Reduction of TRAIL-induced Mcl-1 and cIAP2 by c-Myc or sorafenib sensitizes resistant human cancer cells to TRAIL-induced death.

Authors:  M Stacey Ricci; Seok-Hyun Kim; Kazuhiro Ogi; John P Plastaras; Jianhua Ling; Wenge Wang; Zhaoyu Jin; Yingqiu Y Liu; David T Dicker; Paul J Chiao; Keith T Flaherty; Charles D Smith; Wafik S El-Deiry
Journal:  Cancer Cell       Date:  2007-07       Impact factor: 31.743

10.  Mcl-1 as a buffer for proapoptotic Bcl-2 family members during TRAIL-induced apoptosis: a mechanistic basis for sorafenib (Bay 43-9006)-induced TRAIL sensitization.

Authors:  Xue Wei Meng; Sun-Hee Lee; Haiming Dai; David Loegering; Chunrong Yu; Karen Flatten; Paula Schneider; Nga T Dai; Shaji K Kumar; B Douglas Smith; Judith E Karp; Alex A Adjei; Scott H Kaufmann
Journal:  J Biol Chem       Date:  2007-08-13       Impact factor: 5.157

View more
  35 in total

1.  Glucose-regulated protein 78 mediates the anticancer efficacy of shikonin in hormone-refractory prostate cancer cells.

Authors:  Li-Jen Kuo; Chien-Yu Huang; Wan-Li Cheng; Chin-Sheng Hung; Chun-Te Wu; Feng-Yen Lin; Yu-Jia Chang; Ming-Te Huang
Journal:  Tumour Biol       Date:  2015-02-11

Review 2.  Glucose-regulated proteins in cancer: molecular mechanisms and therapeutic potential.

Authors:  Amy S Lee
Journal:  Nat Rev Cancer       Date:  2014-04       Impact factor: 60.716

3.  Salvianolic acid A attenuates TNF-α- and D-GalN-induced ER stress-mediated and mitochondrial-dependent apoptosis by modulating Bax/Bcl-2 ratio and calcium release in hepatocyte LO2 cells.

Authors:  Xiaojing Yan; Zequn Jiang; Lei Bi; Ye Yang; Weiping Chen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-05-06       Impact factor: 3.000

4.  ER stress regulates myeloid-derived suppressor cell fate through TRAIL-R-mediated apoptosis.

Authors:  Thomas Condamine; Vinit Kumar; Indu R Ramachandran; Je-In Youn; Esteban Celis; Niklas Finnberg; Wafik S El-Deiry; Rafael Winograd; Robert H Vonderheide; Nickolas R English; Stella C Knight; Hideo Yagita; Judith C McCaffrey; Scott Antonia; Neil Hockstein; Robert Witt; Gregory Masters; Thomas Bauer; Dmitry I Gabrilovich
Journal:  J Clin Invest       Date:  2014-05-01       Impact factor: 14.808

5.  Regulation of dimethyl-fumarate toxicity by proteasome inhibitors.

Authors:  Laurence Booth; Nichola Cruickshanks; Seyedmehrad Tavallai; Jane L Roberts; Matthew Peery; Andrew Poklepovic; Paul Dent
Journal:  Cancer Biol Ther       Date:  2014       Impact factor: 4.742

6.  Opposing unfolded-protein-response signals converge on death receptor 5 to control apoptosis.

Authors:  Min Lu; David A Lawrence; Scot Marsters; Diego Acosta-Alvear; Philipp Kimmig; Aaron S Mendez; Adrienne W Paton; James C Paton; Peter Walter; Avi Ashkenazi
Journal:  Science       Date:  2014-07-04       Impact factor: 47.728

7.  Modulation of Navitoclax Sensitivity by Dihydroartemisinin-Mediated MCL-1 Repression in BCR-ABL+ B-Lineage Acute Lymphoblastic Leukemia.

Authors:  Amit Budhraja; Meghan E Turnis; Michelle L Churchman; Anisha Kothari; Xue Yang; Haiyan Xu; Ewa Kaminska; John C Panetta; David Finkelstein; Charles G Mullighan; Joseph T Opferman
Journal:  Clin Cancer Res       Date:  2017-10-03       Impact factor: 12.531

8.  Ferroptosis-inducing agents enhance TRAIL-induced apoptosis through upregulation of death receptor 5.

Authors:  Young-Sun Lee; Dae-Hee Lee; So Yeon Jeong; Seong Hye Park; Sang Cheul Oh; Yong Seok Park; Jian Yu; Haroon A Choudry; David L Bartlett; Yong J Lee
Journal:  J Cell Biochem       Date:  2018-08-30       Impact factor: 4.429

9.  Novel phosphorylation and ubiquitination sites regulate reactive oxygen species-dependent degradation of anti-apoptotic c-FLIP protein.

Authors:  Rachel P Wilkie-Grantham; Shu-Ichi Matsuzawa; John C Reed
Journal:  J Biol Chem       Date:  2013-03-21       Impact factor: 5.157

Review 10.  Molecular targets of TRAIL-sensitizing agents in colorectal cancer.

Authors:  Carmine Stolfi; Francesco Pallone; Giovanni Monteleone
Journal:  Int J Mol Sci       Date:  2012-06-25       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.